US Broker Ratings

Janux Therapeutics, Inc. (JANX) Stock Analysis: Biotechnology Pioneer with 256.30% Potential Upside

In the dynamic world of biotechnology, Janux Therapeutics, Inc. (NASDAQ: JANX) stands out as a promising player with a focus on cutting-edge immunotherapies. This clinical-stage biopharmaceutical..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Powerhouse with a 132.91% Potential Upside

Crinetics Pharmaceuticals, Inc. (CRNX), a San Diego-based biotechnology firm, is currently capturing the attention of investors with its promising pipeline and significant potential upside. The company..

Celldex Therapeutics (CLDX) Stock Analysis: Exploring a Potential 187.80% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing opportunity for investors in the biotechnology sector, primarily due to its promising pipeline in therapeutic antibodies and an..

LivaNova PLC (LIVN) Stock Analysis: Unveiling a 35.82% Upside Potential in the Medical Devices Market

LivaNova PLC (NASDAQ: LIVN), a prominent player in the medical devices sector, has positioned itself as an intriguing prospect for investors looking to capitalize on the..

Viking Therapeutics, Inc. (VKTX): Analyst Ratings Highlight a Potential 234% Upside for Investors

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing investor attention with its strong potential for substantial gains. Known for its innovative approach in the biotechnology sector, Viking..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 108% Upside in the Biotech Sector

Investors with an eye on the biotechnology sector should take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). This San Diego-based biopharmaceutical company is making..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 120% Upside in the Biotech Arena

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company based in South San Francisco, California, stands as a significant player in the biotechnology sector. With a market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 37% Potential Upside and Strong Buy Ratings

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, specializes in operating outpatient physical therapy clinics across the United States. Founded in..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Assessing the 133% Upside Potential

Travere Therapeutics, Inc. (NASDAQ: TVTX) presents a compelling opportunity for investors with its focus on rare kidney and metabolic diseases, evidenced by a notable potential upside..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating the Virtual Healthcare Landscape with a 27.83% Upside Potential

Teladoc Health, Inc. (TDOC) stands as a pivotal player in the healthcare sector, specifically within the burgeoning field of health information services. As a pioneer in..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Navigating Rapid Growth Amidst Uncertain Valuation

Ascentage Pharma Group International (AAPG), a prominent player in the healthcare sector, has piqued investor interest with its impressive revenue growth. Despite this promising figure, the..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 24.64% Potential Upside in the Fertility Benefits Market

Progyny, Inc. (NASDAQ: PGNY), a leader in fertility and family-building healthcare solutions, presents an intriguing opportunity for investors in the healthcare sector. With a market capitalization..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 92% Potential Upside for Investors

Astrana Health Inc. (NASDAQ: ASTH), a key player in the healthcare management sector, is capturing investor attention with a compelling potential upside of 92.02%. Known for..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 14% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in operating senior living communities across the United States. The company, headquartered..

Structure Therapeutics Inc. (GPCR): Investor Outlook on a Potential 271% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its remarkable potential upside of 271.03%, positioning itself as a noteworthy player in the..

ICU Medical, Inc. (ICUI) Stock Analysis: A 39.75% Potential Upside Awaits Investors

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors seeking exposure..

PACS Group, Inc. (PACS) Stock Analysis: A Robust 250% Potential Upside Ignites Investor Interest

Investors looking for opportunities in the healthcare sector may find PACS Group, Inc. (PACS) intriguing, with its promising potential upside of 250.10%. Headquartered in Farmington, Utah,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A 24% Upside Potential Amidst a Challenging Revenue Landscape

Pediatrix Medical Group, Inc. (NASDAQ: MD) stands as a notable player in the healthcare sector, specializing in providing newborn, maternal-fetal, and pediatric subspecialty care services across..

Clover Health Investments (CLOV): Analyzing a 60% Potential Upside with a Focus on Revenue Growth

Clover Health Investments, Corp. (NASDAQ: CLOV) stands out in the healthcare sector with a compelling narrative that combines robust revenue growth with significant potential upside. This..

Kestra Medical Technologies (KMTS) Stock Analysis: Unpacking the 65% Potential Upside

For investors keen on the healthcare sector, Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) presents a compelling opportunity with its significant potential upside of 65.17%. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds